21 May 2013
Keywords: 3-month, fda, delay, takeda, gerd, drug, food
Article | 27 October 2008
The US Food and Drug Administration says that its decision on whether to approve Takeda's gastroesophageal reflux disease drug, TAK-390 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 October 2008
20 May 2013
© 2013 thepharmaletter.com